Gilead Sciences

Gilead Sciences is a biotechnology company located in the United States. It is responsible for discovering, developing, and commercializing various therapeutics. Since Gilead’s founding, it has concentrated primarily on antiviral drugs designed to treat patients infected with influenza, hepatitis B, or human immunodeficiency virus (HIV). As of 2006, Gilead had acquired two additional companies that were focused on developing pulmonary disease drugs. The company has 14 products and/or treatments on the market as of 2014, though this is expected to increase in the coming years.

Gilead was founded and is headquartered in Foster City, California, with additional facilities in Australia and Europe. By the end of 2009, Gilead had about 4,000 full-time employees. The company’s name and logo have their origins in the Bible, which refers ...